(London – March 9, 2022) Kheiron Medical Technologies has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Kheiron has pioneered the development and deployment of artificial intelligence solutions to help radiologists detect breast cancer earlier, and the company is currently leveraging its existing technologies and expertise to expand into new cancer types.
Coming in at #5 for the Most Innovative Company in Europe, Middle East, and Africa, Kheiron is joining the ranks of businesses that are making the biggest impact on their industries and culture as a whole—ultimately thriving in today’s ever-changing world. These companies are creating the future today with some of the most inspiring accomplishments of the 21st century.
“Our AI technology is not just getting world-leading results in clinical studies, it’s helping real patients today,” said Dr. Peter Kecskemethy, CEO and co-founder of Kheiron. “We know that Mia®, our breast screening technology, is recommending recall for breast cancers that radiologists have missed. To have our technology and achievements recognised by Fast Company is a powerful endorsement of our mission to improve cancer diagnostics radically so that everyone has a better fighting chance against this disease that impacts us all.”
Underlying the ability of Kheiron’s technology to support radiologists to pick up cancers earlier is a platform that generates unique data and enables the development of algorithms that can perform at levels previously unachievable. Whilst many AI technologies are not designed to be inclusive, Kheiron’s technology has been built from the get go with diverse populations in mind. This means its AI technology works at new sites and on unseen data for diverse populations.
“Previously other AI solutions have marked areas of suspicion on radiology images that were distracting for radiologists,” said Tobias Rijken, Kheiron’s Chief Technology Officer and co-founder. “Our technology has European regulatory clearance to actually read the mammograms, just like a radiologist would, and make a recommendation as to whether a woman should be called back for further assessment. We are building solutions to help radiologists, not replace them, and our AI-driven cancer diagnostics will enable a new level of support. ”
Fast Company’s editors and writers sought out the most groundbreaking businesses across the globe and industries. They also judged nominations received through their application process.
The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a roadmap for the future of innovation across the most dynamic sectors of the economy.
“The world’s most innovative companies play an essential role in addressing the most pressing issues facing society, whether they’re fighting climate change by spurring decarbonization efforts, ameliorating the strain on supply chains, or helping us reconnect with one another over shared passions,” said Fast Company Deputy Editor David Lidsky.
About Kheiron Medical Technologies
Founded in 2016 by Peter Kecskemethy and Tobias Rijken, Kheiron Medical Technologies is an applied science company focused on supporting cancer diagnostics with machine learning that works with radiologists so that every patient has a better fighting chance. Its initial focus is improving the outcomes for the more than two million women diagnosed globally every year with breast cancer. Operating in the United Kingdom, United States, and Europe, Kheiron is an international, multi-disciplinary team of senior clinicians, industry experts, engineers and machine learning scientists.
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.
For more information, please contact:
VP, Global Commercial Marketing
Kheiron Medical Technologies
11th May 2022
Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel are trailblazers at the forefront of introducing innovative breast imaging technologies into clinical practice (London ...Read more
4th May 2022
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in...Read more
9th March 2022
This AI cancer diagnostics company joins the ranks of Canva, Microsoft, SpaceX, and other winning companies that are changing lives for the better (London – March 9, 20...Read more
30th November 2021
As Head of Machine Learning Research, Glocker will help make sure that Kheiron’s algorithms generalize and can help patients, regardless of their ethnic background or where they ...Read more
29th November 2021
AI-Enabled Scheduling Tool That Focuses Attention on Women Who Need Breast Screening the Most Nov. 29, 2021 – As many as 3.9 million women in the U.S. missed their routine ma...Read more
29th November 2021
Collaboration leverages Stanford’s clinical expertise and Kheiron’s machine learning capabilities to assist radiologists in more effectively staging and monitoring treatment re...Read more
29th November 2021
Award-Winning AI Solutions Developer Launches Image Quality Assurance Tool to Support Radiographers and Radiologists in Breast Screening Process Nov. 29, 2021 – To aid breast...Read more
27th October 2021
“The study will provide evidence to help assess whether the use of AI in this instance could be a viable option,” said Dr William Teh, clinical lead with Royal Free London NHS ...Read more
27th October 2021
Partnership marks significant step in the journey to build evidence base to demonstrate effectiveness and safety of AI in NHS breast cancer screening LONDON, 26 October 2021–&nbs...Read more